Hengxi Jin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hengxi Jin has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Jiang Ji
Department of Dermatology, The Second Affiliated Hospital of Soochow University, Suzhou, China
1 shared publication - Lu Chen
Department of Dermatology, The Second Affiliated Hospital of Soochow University, Suzhou 215000, China
1 shared publication - Xiaoyan Zhang
Department of Dermatology, The Second Affiliated Hospital of Soochow University, Suzhou 215000, China
1 shared publication - Ying Zhao
Department of Dermatology, The Second Affiliated Hospital of Soochow University, Suzhou 215000, China
1 shared publication - Zhongwei Zhang
Department of Infectious Diseases, Tongji Hospital, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious Disease, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
1 shared publication
Latest Publications
- Open Access
- 15 March 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (3) , 454
Histamine Intolerance—A Kind of Pseudoallergic Reaction
Histamine intolerance (HIT) is a common disorder associated with impaired histamine metabolism. Notwithstanding, it is often misdiagnosed as other diseases because of its lack of specific clinical manifestations. HIT did not gain traction until the early 21st century. In this review, we will focus on the latest research and elaborate on the clinical manifestations of HIT, including its manifestations in special populations such as atopic dermatitis (AD) and chronic urticaria (CU), as well as the latest understanding of its etiology and pathogenesis. In addition, we will explore the latest treatment strategies for HIT and the treatment of specific cases.
- 15 March 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (3) , 454
Open AccessHistamine Intolerance—A Kind of Pseudoallergic Reaction
Histamine intolerance (HIT) is a common disorder associated with impaired histamine metabolism. Notwithstanding, it is often misdiagnosed as other diseases because of its lack of specific clinical manifestations. HIT did not gain traction until the early 21st century. In this review, we will focus on the latest research and elaborate on the clinical manifestations of HIT, including its manifestations in special populations such as atopic dermatitis (AD) and chronic urticaria (CU), as well as the latest understanding of its etiology and pathogenesis. In addition, we will explore the latest treatment strategies for HIT and the treatment of specific cases.